格隆汇2月27日丨荣昌生物(688331.SH)公布2024年度业绩快报,报告期内,公司实现营业收入171,540.42万元,同比增加58.40%;实现归属于母公司所有者的净利润-146,786.25万元;实现归属于母公司所有者的扣除非经常性损益的净利润-150,039.33万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.